All News

The FDA approves pitolisant for pediatric cataplexy, offering a rare noncontrolled narcolepsy option with real-world safety data and key interaction tips.

Positive phase 3 data from its KALOS and LOGOS trials show the efficacy and safety of Breztri compared with 2 additional therapies.

Through a mathematical model used to assess asthma dynamics, researchers explore how active smoking can impact disease outcomes.

With expanding scopes of practice, there has never been a better time to introduce or expand clinical services that improve patient outcomes.

Tennessee’s 2024 expansion of pharmacist's scope of practice authorizes independent prescribing and test-and-treat services, positioning pharmacists as primary care extenders in underserved communities.

Understanding acceptable thresholds helps prevent unnecessary discontinuation of guideline-directed therapy.

In a move that comes as a surprise to Moderna and various vaccine experts, the FDA continues its skeptic exploration of mRNA vaccine technology.

Amid evolving standards of care in the management of diabetes, researchers explore the role of pharmacists in facilitating continuous glucose monitoring education.

The decision removes risk statements regarding cardiovascular disease, breast cancer, and probable dementia from the boxed warning.

GLP-1 therapies lower C-reactive protein and tumor necrosis factor-alpha, signaling cardiovascular protection; pharmacists tackle cost

Acoltremon ophthalmic solution effectively increases tear production for dry eye disease, demonstrating benefits and a favorable safety profile in clinical trials.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; provided much-needed nuance to the evolving nature of DTP pharmacy models in today’s landscape.

Phase 3 OCEANIC-STROKE shows asundexian cuts recurrent ischemic stroke by 26% on top of antiplatelets, without more major bleeding.

In what reports are calling a landmark settlement, Cigna agrees to make good on years of unfair business dealings that have affected patients and independent pharmacies.

Exploring the perspectives of health care professionals, researchers test the feasibility of the Asthma Care from Home project.

Pharmacists guide smokers in choosing effective OTC cessation aids, enhancing success rates with tailored nicotine replacement therapies for cravings and withdrawal relief.

Real-world data shows empagliflozin cuts mortality in broader type 2 diabetes patients, supporting wider sodium-glucose co-transporter 2 inhibitor use with careful safety monitoring.

Phase 3 data show oral fenebrutinib slows primary progressive multiple sclerosis disability progression versus ocrelizumab, with early upper-limb gains and a manageable safety profile.

HIV care faces challenges from persistent stigmas and misinformation, hindering effective prevention and treatment integration into primary health care.

Pharmacists play an important role in guiding safe and effective OTC pain management, ensuring optimal patient care and minimizing risks.

CDC updates vaccination guidelines, emphasizing individual choice for COVID-19 and standalone chickenpox shots, while addressing vaccine hesitancy and misinformation.

TrumpRx drives Most-Favored-Nation drug pricing, cutting US costs for glucagon-like peptide-1, insulin, and fertility medications.

Anne Cassity, senior vice president of government affairs at NCPA, discusses the next moves of both PBMs and community pharmacy advocates following the signing of HR 7148.

As provisions begin rolling out over the next few years, community pharmacies will no longer be at the will of unfair reimbursement and contracting terms.

Pharmacists evolve from ancient healers to vital health care providers, enhancing patient care and accessibility in today's strained health system.

Pfizer's phase 2b study reveals promising results for its monthly GLP-1 therapy, enhancing weight loss and medication adherence in obesity management.

IBSA’s formulation of sildenafil, known as Vybrique, will hit the market in March 2026 as the first and only oral film that treats erectile dysfunction.

With infectious disease rates expected to jump as US vaccine schedules are reworked, antimicrobial stewardship programs are seeking community pharmacists.